Clinical Trial Update: Open Trail of γIFN for Friedreich Ataxia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of gamma-interferon for Friedreich ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• gammaIFN (gamma-interferon)

Snippet

Sponsor: IRCCS Eugenio Medea | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED